Science and the Stimulus, Improving Biomarker Discovery, Betting on Genomics, more | GenomeWeb

Predicting the future of research and betting on the next big thing are recurring themes in science. In May 2001, Genome Technology spoke with venture capitalists, analysts, and company finance officers about the future of genomics and investing in the technology that was just getting off the ground. Noubar Afeyan, then a managing partner of venture capital firm Applied Genomic Technology Capital Fund, said he considered both technology vendors and companies dedicated to discovery to be good investment opportunities.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.